Sensyne Health (SENS) Reaches New 12-Month Low at $150.00

Shares of Sensyne Health PLC (LON:SENS) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 150 ($1.96) and last traded at GBX 154 ($2.01), with a volume of 8113 shares traded. The stock had previously closed at GBX 160 ($2.09).

Separately, Peel Hunt reiterated a “buy” rating on shares of Sensyne Health in a research report on Tuesday, April 2nd.

The company has a debt-to-equity ratio of 1.60, a quick ratio of 13.22 and a current ratio of 13.29. The stock has a market capitalization of $174.86 million and a PE ratio of 7.47.

ILLEGAL ACTIVITY WARNING: This article was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another website, it was illegally stolen and reposted in violation of United States and international copyright and trademark law. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2019/05/16/sensyne-health-sens-hits-new-1-year-low-at-150-00.html.

About Sensyne Health (LON:SENS)

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.

Further Reading: Quick Ratio

Receive News & Ratings for Sensyne Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensyne Health and related companies with MarketBeat.com's FREE daily email newsletter.